Cargando…

Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?

PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve shea...

Descripción completa

Detalles Bibliográficos
Autores principales: Berzaczy, Dominik, Mayerhoefer, Marius E., Azizi, Amedeo A., Haug, Alexander R., Senn, Daniela, Beitzke, Dietrich, Weber, Michael, Traub-Weidinger, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716584/
https://www.ncbi.nlm.nih.gov/pubmed/29206885
http://dx.doi.org/10.1371/journal.pone.0189093
_version_ 1783283979740250112
author Berzaczy, Dominik
Mayerhoefer, Marius E.
Azizi, Amedeo A.
Haug, Alexander R.
Senn, Daniela
Beitzke, Dietrich
Weber, Michael
Traub-Weidinger, Tatjana
author_facet Berzaczy, Dominik
Mayerhoefer, Marius E.
Azizi, Amedeo A.
Haug, Alexander R.
Senn, Daniela
Beitzke, Dietrich
Weber, Michael
Traub-Weidinger, Tatjana
author_sort Berzaczy, Dominik
collection PubMed
description PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). RESULTS: A total of 12 (6 male/6 female, mean age was 16.2 ± 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -.441) and ADCmin (r = -.477), which proved to be statistically significant (p = .005 and p = .002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -.311) and ADCmin (r: -.300) and did not reach statistical significance (p = .054 and p = .057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r = .353; p = .027) and a strong one for SUVmean (r = .879; p = .001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r = .827; p < .001 and r = .721; p < .001) but differed significantly (p < .001). CONCLUSIONS: We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST.
format Online
Article
Text
id pubmed-5716584
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57165842017-12-15 Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? Berzaczy, Dominik Mayerhoefer, Marius E. Azizi, Amedeo A. Haug, Alexander R. Senn, Daniela Beitzke, Dietrich Weber, Michael Traub-Weidinger, Tatjana PLoS One Research Article PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). RESULTS: A total of 12 (6 male/6 female, mean age was 16.2 ± 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -.441) and ADCmin (r = -.477), which proved to be statistically significant (p = .005 and p = .002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -.311) and ADCmin (r: -.300) and did not reach statistical significance (p = .054 and p = .057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r = .353; p = .027) and a strong one for SUVmean (r = .879; p = .001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r = .827; p < .001 and r = .721; p < .001) but differed significantly (p < .001). CONCLUSIONS: We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST. Public Library of Science 2017-12-05 /pmc/articles/PMC5716584/ /pubmed/29206885 http://dx.doi.org/10.1371/journal.pone.0189093 Text en © 2017 Berzaczy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Berzaczy, Dominik
Mayerhoefer, Marius E.
Azizi, Amedeo A.
Haug, Alexander R.
Senn, Daniela
Beitzke, Dietrich
Weber, Michael
Traub-Weidinger, Tatjana
Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title_full Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title_fullStr Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title_full_unstemmed Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title_short Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
title_sort does elevated glucose metabolism correlate with higher cell density in neurofibromatosis type 1 associated peripheral nerve sheath tumors?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716584/
https://www.ncbi.nlm.nih.gov/pubmed/29206885
http://dx.doi.org/10.1371/journal.pone.0189093
work_keys_str_mv AT berzaczydominik doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT mayerhoefermariuse doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT aziziamedeoa doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT haugalexanderr doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT senndaniela doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT beitzkedietrich doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT webermichael doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors
AT traubweidingertatjana doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors